首页> 美国卫生研究院文献>Global Journal of Health Science >Chronic Kidney Disease Screening Methods and Its Implication for Malaysia: An in Depth Review
【2h】

Chronic Kidney Disease Screening Methods and Its Implication for Malaysia: An in Depth Review

机译:慢性肾脏病筛查方法及其对马来西亚的意义:深度回顾

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Chronic Kidney Disease has become a public health problem, imposing heath, social and human cost on societies worldwide. Chronic Kidney Disease remains asymptomatic till late stage when intervention cannot stop the progression of the disease. Therefore, there is an urgent need to detect the disease early. Despite the high prevalence of Chronic Kidney Disease in Malaysia, screening is still lacking behind. This review discusses the strengths and limitations of current screening methods for Chronic Kidney Disease from a Malaysian point of view. Diabetic Kidney Disease was chosen as focal point as Diabetes is the leading cause of Chronic Kidney Disease in Malaysia. Screening for Chronic Kidney Disease in Malaysia includes a urine test for albuminuria and a blood test for serum creatinine. Recent literature indicates that albuminuria is not always present in Diabetic Kidney Disease patients and serum creatinine is only raised after substantial kidney damage has occurred. Recently, cystatin C was proposed as a potential marker for kidney disease but this has not been studied thoroughly in Malaysia. Glomerular Filtration Rate is the best method for measuring kidney function and is widely estimated using the Modification of Diet for Renal Disease equation. Another equation, the Chronic Kidney Disease Epidemiology Collaboration Creatinine equation was introduced in 2009. The new equation retained the precision and accuracy of the Modification of Diet for Renal Disease equation at GFR < 60ml/min/1.73m2, showed less bias and improved precision at GFR>60ml/min/1.73m2. In Asian countries, adding an ethnic coefficient to the equation enhanced its performance. In Malaysia, a multi-ethnic Asian population, the Chronic Kidney Disease Epidemiology Collaboration equation should be validated and the Glomerular Filtration Rate should be reported whenever serum creatinine is ordered. Reporting estimated Glomerular Filtration Rate will help diagnose patients who would have been otherwise missed if only albuminuria and serum creatinine are measured.
机译:慢性肾脏病已经成为一种公共卫生问题,给全世界的社会带来了健康,社会和人类的负担。慢性肾脏病一直没有症状,直到晚期不能干预时才停止。因此,迫切需要及早发现该疾病。尽管马来西亚的慢性肾脏病患病率很高,但筛查工作仍然落后。本文从马来西亚的角度讨论了目前慢性肾脏病筛查方法的优势和局限性。糖尿病肾病被选为焦点,因为糖尿病是马来西亚慢性肾脏病的主要原因。在马来西亚,慢性肾脏病的筛查包括尿蛋白检查和血清肌酐的检查。最近的文献表明,在糖尿病性肾脏病患者中并不总是存在白蛋白尿,仅在发生实质性肾脏损害后才升高血清肌酐。最近,半胱氨酸蛋白酶抑制剂C被提议作为肾脏疾病的潜在标志物,但马来西亚尚未对此进行深入研究。肾小球滤过率是测量肾功能的最佳方法,并且使用“肾脏疾病饮食的修正”公式进行了广泛估计。另一个方程式,即慢性肾脏病流行病学协作性肌酐方程,于2009年引入。新方程式保留了GFR <60ml / min / 1.73m 2 的肾脏疾病饮食饮食调整的精度和准确性。 ,在GFR> 60ml / min / 1.73m 2 时显示较少的偏差并提高了精度。在亚洲国家/地区,将种族系数添加到方程式中可提高其性能。在马来西亚(一个多种族的亚洲人)中,每当订购血清肌酐时,就应验证慢性肾脏病流行病学协作方程,并报告肾小球滤过率。报告估计的肾小球滤过率将有助于诊断仅测量白蛋白尿和血清肌酐的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号